Effectiveness of Kabasura Kudineer tablets in the management of asymptomatic and mild cases of COVID-19: A pilot double-blinded, randomized controlled trial

Author:

Khapre MinakshiORCID,Pathania MonikaORCID,Saxena Vartika,Omar Balram JI.ORCID,Goyal Bela,Sinha Smita,Bahurupi Yogesh,Dhamija Puneet

Publisher

Elsevier BV

Subject

Complementary and alternative medicine,Drug Discovery

Reference35 articles.

1. Investigate the origins of COVID-19;Bloom;Science,2021

2. WHO Director-General’s opening remarks at the media briefing on COVID-19 - 11 March 2020. Available from: https://www.who.int/director-general/speeches/detail/who-director-general-s-opening-remarks-at-the-media-briefing-on-covid-19---11-march-2020. Retrieved 11 July 2021.

3. World Health Organization. WHO Coronavirus (COVID-19) Dashboard. Available from: https://covid19.who.int/?mapFilter=vaccinations. Retrieved 13 July 2021.

4. Science TW. Chart: The Global Problem of Underreporting COVID-19 Deaths. Available from: https://science.thewire.in/health/chart-the-global-problem-of-underreporting-COVID-19-deaths/.Retrieved 13 July 2021.

5. Everything you need to know about the COVID-19 therapy trials;Robinson;Pharmaceut J,2023

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3